Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Aortech International Plc LSE:AOR London Ordinary Share GB0033360586 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  7.50 7.69% 105.00 100.00 110.00 105.00 97.50 97.50 75,872 14:23:56
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.5 -0.6 -4.7 - 17

Aortech Share Discussion Threads

Showing 8751 to 8774 of 8775 messages
Chat Pages: 351  350  349  348  347  346  345  344  343  342  341  340  Older
DateSubjectAuthorDiscuss
26/5/2020
18:48
I get the impression that whilst covid issues are disrupting production of products for customers , it is full steam ahead on developing its own devices and IP surrounding them and would not be surprised to see a stream of news into the summer. As mentioned by others the positive tone from the company recently from a historically conservative BOD is telling.
landy90
26/5/2020
18:33
Two more late reported 25k trades reported from Friday morning which makes four of that size in recent days. Silent accumulation by serious players?
bones
26/5/2020
18:29
Regarding the resumption of heart surgery in the US, the linked article below gives an indication of the headaches faced by the hospitals, namely always needing to allow for Covid waves but also to “entice” those with serious health problems to actually attend hospital!! However, this quote sounds like it might be what RUA Medical needs to hear: “... Similarly, at WVU Medicine, a committee consisting of representatives from every surgical department meets daily to review every case. Those with significant heart and valve and blood vessel diseases have been prioritized in Phase 1, as have some cancer patients, Hoffmann says. “Every physician feels like their case is important, but we have to look at the big picture,” he says. “It’s a little bit of numbers but then also some decision-making among physicians and administrative staff ...” https://www.aamc.org/news-insights/hospitals-cautiously-resume-some-surgeries
bones
26/5/2020
13:24
cfb2, lol!
bones
26/5/2020
13:09
Cheers landy Edwards Lifestyles Corp NYSE:EW. Market Cap 45bn
someuwin
26/5/2020
12:56
Germany are paying 35k Euro and its about $45k in the US.
landy90
26/5/2020
12:43
£20k is the device not the op... The patient being handed the bill would be when they stress test the valve.
cfb2
26/5/2020
12:18
No online quote for even small amounts, got to let this go soon.
nimbo10
26/5/2020
12:12
Blimey...that's quite an eye-opener.
langland
26/5/2020
12:05
£20k is the device not the op, that is what has driven the share price of Edwards over the last 10 years TAVI devices are circa 10X surgical valves.
landy90
26/5/2020
11:50
The Takeover / merger with RUA Medical will bring a huge amount of new opportunities. The experience and no doubt long list of clients will be hugely advantageous. I suspect there's a lot more going on in the background here than we are aware of - yet! "Here are a range of medical device products and systems that the RUA Medical team have worked on: * Straight, tapered and bifurcated vascular and endovascular tubular implants * Male and Female Urinary Incontinence systems * Mechanised sewing of wire scaffolds onto circular, tapered and bifurcated endovascular implant fabrics. * Woven tapered bifurcated vascular and endovascular delivery systems * Spinal lumber stabilisation implants * AAA and thoracic stent grafts * Synthetic spinal disc replacement implants * Pelvic organ prolapse mesh systems * 3D tissue growth support scaffolds (permanent & reabsorbable) * Synthetic ligaments * PTFE mesh and implantable fabrics * Hernia mesh systems * Reabsorbable and composite mesh systems * Cuff fabrics * Stent covering systems * Knitted pessary system * Medical Coatings * Silver Ion release urology catheters. * Reabsorbable and composite mesh systems * Antimicrobial solutions * Alginate wound care systems * Personal care systems * Catheter securement system * Braided Suture Systems * Blood monitoring system * Heart Surgery retractor * Knitted and woven dental floss systems * Single use instruments"
someuwin
26/5/2020
11:38
If you include the cost of the operation 20k seems about right.
cfb2
26/5/2020
11:03
Nice move todayGreat long term hold here
herschel k
26/5/2020
11:01
Donalc....yes, sure, I, personally, did not think it was 20k per actual valve though I can see that the article may suggest that.
langland
26/5/2020
10:41
Langland- I believe that figure will be price of the whole TAVE service- admission, staff, theatre, possibility of it going wrong and extended stay in ICU etc will all be covered by that figure- "PBR" used to be the term, though contracts now tending to move back to block contracting, though managers will still think in terms of what is cost base for each intervention.
donalc
26/5/2020
09:51
Just been offered 98p for 50,000
25october1969
26/5/2020
09:35
So, the MM’s are bidding hard to get stock!
bones
26/5/2020
09:26
Not seen this before with AOR but can currently sell 50k at 97. Nothing on offer (to speak of).
langland
26/5/2020
09:19
Stock still hard to buy. Can get a buy quote for £2k. But not £3k.
someuwin
26/5/2020
07:33
Further to the above post the attached link provides figures for 2017 for the United States alone. https://idataresearch.com/over-182000-heart-valve-replacements-per-year-in-the-united-states/ The following link provides a better overview. If you scroll down to the 'key players' section, little Aortech is mentioned alongside the likes of Edwards Life Sciences and Medtronic. https://www.medgadget.com/2020/03/heart-valve-repair-and-replacement-market-size-share-global-industry-report-2019-2025.html
langland
25/5/2020
12:24
https://www.telegraph.co.uk/health-fitness/body/pioneering-heart-surgery-saved-life-lockdown/ A very recent patient's story of having a TAVI fitted. AOR is not quite at the TAVI stage but, after the recent developments, this will be next in line for design. https://www.youtube.com/watch?v=3YCMlrPNH_U The above is an Edwards video. In the telegraph article it is interesting that the figure of £20k is mentioned. 'Twelve hours after the operation I walked out of the hospital, a new organic £20,000 valve pumping inside my heart, with the promise I could start jogging again soon.'
langland
22/5/2020
15:41
Fortunately, heart valves are not short term devices. Long term target = the sky. Some short termers are bailing today, so it should get the share register firmer with new blood that looks further than a three day profit!
bones
22/5/2020
15:06
chart looks v positive. S-t target of around 130p
t0pgrader
22/5/2020
13:26
Yes, I agree. This is a company offering disruptive medical tech which already has a captive audience and customers that it applies to.
greedy rooster
Chat Pages: 351  350  349  348  347  346  345  344  343  342  341  340  Older
ADVFN Advertorial
Your Recent History
LSE
AOR
Aortech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200527 01:59:05